Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Mean cell haemoglobin concentration abnormal? 16 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Mean cell haemoglobin concentration abnormal have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.

16
Reports of Mean cell haemoglobin concentration abnormal with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Mean cell haemoglobin concentration abnormal From ADALIMUMAB?

Of the 16 reports, 1 (6.3%) required hospitalization.

Is Mean cell haemoglobin concentration abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Mean cell haemoglobin concentration abnormal?

ETANERCEPT (19) PREDNISONE (18) METHOTREXATE (16) TOFACITINIB (14) ECULIZUMAB (12) HERBALS\TURMERIC (12) LEFLUNOMIDE (12) NABILONE (12) ERGOCALCIFEROL (11) ATORVASTATIN (9)

Which ADALIMUMAB Alternatives Have Lower Mean cell haemoglobin concentration abnormal Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Mean cell haemoglobin concentration abnormal Reports All Drugs Causing Mean cell haemoglobin concentration abnormal ADALIMUMAB Demographics